Medtronic reports first quarter fiscal 2024 financial results

Go back to Medtronic reports first quarter fiscal 2024 financial results

Medtronic, Inc. (MDT) PT Raised to $95 at Stifel

August 22, 2023 3:58 PM EDT

Stifel analyst Rick Wise raised the price target on Medtronic, Inc. (NYSE: MDT) to $95.00 (from $92.00) while maintaining a Buy rating following earnings.

The analyst commented, "CEO Geoff Marthas transformation initiatives were more-visible than we expected, as evidenced by Medtronic's outperformance in what... More

Medtronic (MDT) tops earnings estimates, raises guidance

August 22, 2023 7:33 AM EDT

Medtronic (NYSE: MDT) reported better-than-expected first-quarter earnings. The companys EPS of $1.20 topped the analyst estimate of $1.11.

Revenue for the quarter amounted to $7.7 billion, exceeding the consensus estimate of $7.57B. Cardiovascular Revenue was $2.85B, marking a 5% year-on-year increase. This figure exceeded the... More

Medtronic (MDT) Tops Q1 EPS by 9c; Offers FY23 EPS Guidance

August 22, 2023 6:47 AM EDT

Medtronic (NYSE: MDT) reported Q1 EPS of $1.20, $0.09 better than the analyst estimate of $1.11. Revenue for the quarter came in at $7.7 billion versus the consensus estimate of $7.57 billion.

GUIDANCE:

Medtronic sees FY2024 EPS of $5.08-$5.16, versus the consensus of $5.05.

For earnings history and earnings-related data on Medtronic (MDT) click here.

... More